Search research articles
Contact Us
Filters
Showing results (101-110 of 156) with videos related to
Page
of 16
Sort By:
Antimicrobial Agents and Chemotherapy
|
September 21, 2011
Model-based approach for optimization of atazanavir dose recommendations for HIV-infected pediatric patients
Ying Hong, Kenneth G Kowalski, Jenny Zhang, et al.
Journal of Clinical Pharmacology
|
October 1, 2010
Model-based drug development: strengths, weaknesses, opportunities, and threats for broad application of pharmacometrics in drug development
Jeffrey D Wetherington, Marc Pfister, Christopher Banfield, et al.
Clinical Pharmacokinetics
|
March 15, 2005
Pharmacodynamic analysis of the microbiological efficacy of telithromycin in patients with community-acquired pneumonia
Jun Shi, Marc Pfister, Stephen G Jenkins, et al.
Frontiers in Medicine
|
October 13, 2022
Understanding efficacy-safety balance of biologics in moderate-to-severe pediatric psoriasis
Klervi Golhen, Carolyn Winskill, Martin Theiler, et al.
European Journal of Endocrinology
|
October 6, 2022
Machine learning-based algorithm as an innovative approach for the differentiation between diabetes insipidus and primary polydipsia in clinical practice
Uri Nahum, Julie Refardt, Irina Chifu, et al.
Antimicrobial Agents and Chemotherapy
|
December 25, 2002
Modeling of transfer kinetics at the serum-cerebrospinal fluid barrier in rabbits with experimental meningitis: application to grepafloxacin
Marc Pfister, Liping Zhang, Margareta Hammarlund-Udenaes, et al.
British Journal of Clinical Pharmacology
|
November 20, 2020
Pharmacometric analyses to characterize the effect of CSL112 on apolipoprotein A-I and cholesterol efflux capacity in acute myocardial infarction patients
Bo Zheng, Danielle Duffy, Pierluigi Tricoci, et al.
British Journal of Clinical Pharmacology
|
February 27, 2019
Methadone dosing strategies in preterm neonates can be simplified
Tamara van Donge, Samira Samiee-Zafarghandy, Marc Pfister, et al.
Pharmacology Research & Perspectives
|
July 20, 2023
Modeling time-delayed concentration-QT effects with ACT-1014-6470, a novel oral complement factor 5a receptor 1 (C5a<sub>1</sub> receptor) antagonist
Marion Anliker-Ort, Chih-Hsuan Hsin, Andreas Krause, et al.
Journal of Clinical Pharmacology
|
January 20, 2025
Understanding and Streamlining Dose Finding: From Dose Simulation to Dose Estimation
Dominic Bräm, Freya Bachmann, Johannes Schropp, et al.
Page
of 16
Search research articles
Search
Showing results (101-110 of 156) with videos related to
Sort By:
Page
of 16
Antimicrobial Agents and Chemotherapy
|
September 21, 2011
Model-based approach for optimization of atazanavir dose recommendations for HIV-infected pediatric patients
Ying Hong, Kenneth G Kowalski, Jenny Zhang, et al.
Journal of Clinical Pharmacology
|
October 1, 2010
Model-based drug development: strengths, weaknesses, opportunities, and threats for broad application of pharmacometrics in drug development
Jeffrey D Wetherington, Marc Pfister, Christopher Banfield, et al.
Clinical Pharmacokinetics
|
March 15, 2005
Pharmacodynamic analysis of the microbiological efficacy of telithromycin in patients with community-acquired pneumonia
Jun Shi, Marc Pfister, Stephen G Jenkins, et al.
Frontiers in Medicine
|
October 13, 2022
Understanding efficacy-safety balance of biologics in moderate-to-severe pediatric psoriasis
Klervi Golhen, Carolyn Winskill, Martin Theiler, et al.
European Journal of Endocrinology
|
October 6, 2022
Machine learning-based algorithm as an innovative approach for the differentiation between diabetes insipidus and primary polydipsia in clinical practice
Uri Nahum, Julie Refardt, Irina Chifu, et al.
Antimicrobial Agents and Chemotherapy
|
December 25, 2002
Modeling of transfer kinetics at the serum-cerebrospinal fluid barrier in rabbits with experimental meningitis: application to grepafloxacin
Marc Pfister, Liping Zhang, Margareta Hammarlund-Udenaes, et al.
British Journal of Clinical Pharmacology
|
November 20, 2020
Pharmacometric analyses to characterize the effect of CSL112 on apolipoprotein A-I and cholesterol efflux capacity in acute myocardial infarction patients
Bo Zheng, Danielle Duffy, Pierluigi Tricoci, et al.
British Journal of Clinical Pharmacology
|
February 27, 2019
Methadone dosing strategies in preterm neonates can be simplified
Tamara van Donge, Samira Samiee-Zafarghandy, Marc Pfister, et al.
Pharmacology Research & Perspectives
|
July 20, 2023
Modeling time-delayed concentration-QT effects with ACT-1014-6470, a novel oral complement factor 5a receptor 1 (C5a<sub>1</sub> receptor) antagonist
Marion Anliker-Ort, Chih-Hsuan Hsin, Andreas Krause, et al.
Journal of Clinical Pharmacology
|
January 20, 2025
Understanding and Streamlining Dose Finding: From Dose Simulation to Dose Estimation
Dominic Bräm, Freya Bachmann, Johannes Schropp, et al.
Page
of 16